We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

36 hedge funds and large institutions have $49.4M invested in Axsome Therapeutics in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

13% more capital invested

Capital invested by funds: $43.7M → $49.4M (+$5.71M)

6% more funds holding

Funds holding: 34 → 36 (+2)

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
13
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Stifel Financial
Stifel Financial
Missouri
+$3.14M
2
Northern Trust
Northern Trust
Illinois
+$630K
3
BWP
Baldwin Wealth Partners
Massachusetts
+$115K
4
JMFC
J.M. Forbes & Co
Massachusetts
+$114K
5
Citadel Advisors
Citadel Advisors
Florida
+$99.7K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$286K
2
Goldman Sachs
Goldman Sachs
New York
-$135K
3
LOAMU
Lombard Odier Asset Management (USA)
New York
-$104K
4
Allianz Asset Management
Allianz Asset Management
Germany
-$69.3K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$21.1M – – –
JP Morgan Chase
2
JP Morgan Chase
New York
$12.6M +$80.4K +10,625 +0.7%
Stifel Financial
3
Stifel Financial
Missouri
$3.27M +$3.14M +415,279 New
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$2.58M -$104K -13,729 -4%
BFA
5
BlackRock Fund Advisors
California
$2.37M +$93.6K +12,367 +4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2M +$44K +5,812 +2%
State Street
7
State Street
Massachusetts
$996K +$96.4K +12,731 +11%
Allianz Asset Management
8
Allianz Asset Management
Germany
$847K -$69.3K -9,150 -8%
Northern Trust
9
Northern Trust
Illinois
$827K +$630K +83,265 +384%
BIT
10
BlackRock Institutional Trust
California
$442K +$4.25K +561 +1%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$387K +$6.09K +805 +2%
Mariner
12
Mariner
Kansas
$355K +$26.3K +3,475 +8%
BIM
13
BlackRock Investment Management
Delaware
$299K -$924 -122 -0.3%
California State Teachers Retirement System (CalSTRS)
14
California State Teachers Retirement System (CalSTRS)
California
$183K -$757 -100 -0.4%
Morgan Stanley
15
Morgan Stanley
New York
$172K -$286K -37,786 -63%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$169K – – –
Charles Schwab
17
Charles Schwab
California
$140K – – –
TA
18
Teachers Advisors
New York
$134K – – –
JMFC
19
J.M. Forbes & Co
Massachusetts
$119K +$114K +15,066 New
BWP
20
Baldwin Wealth Partners
Massachusetts
$119K +$115K +15,151 New
Citadel Advisors
21
Citadel Advisors
Florida
$104K +$99.7K +13,171 New
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$66K – – –
NFA
23
Nationwide Fund Advisors
Ohio
$51K – – –
AIG
24
American International Group
New York
$50.5K +$68 +9 +0.1%
BA
25
BlackRock Advisors
Delaware
$35K +$11.8K +1,558 +55%
1
2

AXSM Hedge Fund Activity: Q3 2016 in Review

36 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q3 2016, worth a combined $49.4M — up 13% from $43.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AXSM positions and 4 closed out — a net gain of 2 holders — while 13 added to existing stakes and 8 trimmed.

The largest buyer was Stifel Financial, opening a new position worth an estimated $3.14M. The largest seller was Morgan Stanley, cutting an estimated $286K.

  • 36 institutional investors held Axsome Therapeutics (AXSM) as of Q3 2016, up from 34 in Q2 2016.
  • Funds reported $49.4M of Axsome Therapeutics stock for Q3 2016, up 13% quarter-over-quarter.
  • 6 funds opened new Axsome Therapeutics positions in Q3 2016 and 4 closed out, a net change of +2 holders.
  • The largest Axsome Therapeutics buyer in Q3 2016 was Stifel Financial, an estimated $3.14M added.
  • The largest Axsome Therapeutics seller in Q3 2016 was Morgan Stanley, an estimated $286K sold.

Based on aggregated 13F filings for Q3 2016.